Related Experiment Video

Updated: May 22, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Tweaking the cholesterol efflux capacity of reconstituted HDL

Cheng-I J Ma1, Jennifer A Beckstead, Airlia Thompson

  • 1Cardiovascular Research Laboratories, Department of Medicine, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, QC H3A 1A1, Canada.

Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|May 22, 2012
PubMed

Insights

Reconstituted HDL (rHDL) with apoA-I Milano and sphingomyelin showed the highest cholesterol efflux from cells. This finding is key for developing new therapies to reduce heart disease risk.

Area of Science:

  • Cardiovascular Research
  • Lipid Metabolism
  • Biochemistry

Background:

  • Increasing high-density lipoprotein (HDL) or promoting cellular cholesterol egress is crucial for reversing heart disease.
  • Reconstituted HDL (rHDL) is a promising therapeutic agent for enhancing cholesterol removal from cells.
  • Foam cells in atherosclerotic lesions are key targets for cholesterol egress strategies.

Purpose of the Study:

  • To evaluate the cholesterol efflux capacity of different reconstituted HDL (rHDL) formulations.
  • To investigate the influence of apolipoprotein A-I (apoA-I) variants and phospholipid composition on rHDL function.
  • To understand the role of specific transporters (ABCG1, ABCA1) in mediating rHDL-induced cholesterol efflux.

Main Methods:

  • Preparation of four distinct rHDL particles using wild type apoA-I or apoA-I Milano (M) with phosphatidylcholine (PC) or sphingomyelin (SM).
  • Incubation of rHDL with CHO cells, J774 macrophages, and BHK cells to assess cellular cholesterol efflux.
  • Manipulation of ABCG1 and ABCA1 transporter expression in cells to determine their involvement in efflux.
  • Binding experiments to confirm interactions between rHDL and ABCA1.

Main Results:

  • The apoA-I Milano (M) sphingomyelin (SM)-rHDL formulation demonstrated the highest cholesterol efflux across all tested cell types.
  • Increased expression of ABCG1 significantly enhanced cholesterol efflux mediated by all tested rHDL particles in BHK cells.
  • Efflux to PC-containing rHDL was stimulated by a nonfunctional ABCA1 mutant, suggesting ABCA1 binding competes with efflux.
  • Cholesterol efflux activity is dependent on both the apoA-I protein and the phospholipid component of rHDL.

Conclusions:

  • The specific composition of rHDL, particularly the apoA-I variant and phospholipid type, critically determines its cholesterol efflux capacity.
  • ApoA-I Milano (M) combined with sphingomyelin represents a highly effective formulation for promoting cholesterol efflux.
  • Understanding the interplay between rHDL composition and cellular transporters like ABCG1 and ABCA1 is vital for optimizing therapeutic rHDL strategies.
  • These findings support the development of targeted rHDL interventions to regress atherosclerotic lesions and reduce cardiovascular disease.

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...